{"id":115486,"date":"2026-06-12T11:10:00","date_gmt":"2026-06-12T05:40:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=115486"},"modified":"2026-06-12T11:10:02","modified_gmt":"2026-06-12T05:40:02","slug":"dabur-share-price-usfda-import-alert-silvassa-plant","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dabur-share-price-usfda-import-alert-silvassa-plant\/","title":{"rendered":"Dabur Share Price in Focus After USFDA Issues Import Alert for Silvassa Plant \u2014 Stock Holds at Rs 424.45; What This Means for Investors"},"content":{"rendered":"
<\/div>\n

Dabur share price: Rs 424.45 (+Rs 2.75, +0.65%) | Open Rs 421.00, High Rs 429.05, Low Rs 420.95 | Prev close Rs 421.70 | USFDA import alert: drugs made at Silvassa plant (Dadra and Nagar Haveli). Market reaction: mildly positive , limited scope relative to Dabur’s overall FMCG business.<\/em><\/p>\n

Dabur<\/a> share price<\/strong> is in focus today after the US Food and Drug Administration (USFDA) issued an import alert for drugs manufactured at Dabur’s Silvassa plant in Dadra and Nagar Haveli. Despite the negative regulatory development, the Dabur share price<\/strong> is trading at Rs 424.45, up 0.65% from its previous close of Rs 421.70, with the stock opening at Rs 421 and touching a high of Rs 429.05 during the session. The market’s muted-to-positive reaction reflects the limited scope of the USFDA alert relative to Dabur’s overall business: the company is primarily an FMCG player (oral care, hair care, consumer healthcare) with pharmaceutical exports to the US representing a small fraction of revenue. An USFDA import alert restricts imports of specific products from the flagged facility into the US until the manufacturer addresses the regulatory observations and receives clearance.<\/p>\n

Click Here – Get Free Research From Univest<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n